Company
BioXcel Therapeutics, Inc.
Headquarters: New Haven, CT, United States
Employees: 89
CEO: Dr. Vimal D. Mehta Ph.D.
Market Cap
$16.9 Million
USD as of Jan. 1, 2025
BioXcel Therapeutics, Inc. Categories
United States Healthcare BiotechnologyUnited States Healthcare United States Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immune activator for the treatment of prostate and pancreatic cancers, and solid tumors. BioXcel Therapeutics, Inc. has a collaboration with collaboration with the VA Connecticut Healthcare System and the Yale University Medical School for patients suffering from post-traumatic stress disorder related to alcohol and substance abuse disorder. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $1.4 M |
| EBITDA | $-167,300,992 |
| Gross Profit TTM | $120,000 |
| Profit Margin | 8.70% |
| Operating Margin | -5285.90% |
| Quarterly Revenue Growth | 58.00% |
Stocks & Indices
BioXcel Therapeutics, Inc. has the following listings and related stock indices.
Stock: NASDAQ: BTAI wb_incandescent
Stock: FSX: BX2 wb_incandescent